Search Results - "Ananthakrishnan, N."

Refine Results
  1. 1

    Environmental Risk Factors for Inflammatory Bowel Diseases: A Review by Ananthakrishnan, Ashwin N.

    Published in Digestive diseases and sciences (01-02-2015)
    “…Inflammatory bowel diseases comprising Crohn’s disease (CD) and ulcerative colitis (UC) are chronic immunologically mediated diseases. The key mechanism…”
    Get full text
    Journal Article
  2. 2

    Epidemiology and risk factors for IBD by Ananthakrishnan, Ashwin N.

    “…Key Points Crohn's disease and ulcerative colitis are complex immunologically mediated diseases that arise due to a dysregulated immune response to commensal…”
    Get full text
    Journal Article
  3. 3

    ACG Clinical Guideline: Ulcerative Colitis in Adults by Rubin, David T, Ananthakrishnan, Ashwin N, Siegel, Corey A, Sauer, Bryan G, Long, Millie D

    Published in The American journal of gastroenterology (01-03-2019)
    “…Ulcerative colitis (UC) is an idiopathic inflammatory disorder. These guidelines indicate the preferred approach to the management of adults with UC and…”
    Get full text
    Journal Article
  4. 4

    Clostridium difficile infection: epidemiology, risk factors and management by Ananthakrishnan, Ashwin N

    “…Clostridium difficile is as an important health-care-associated pathogen and is linked to significant morbidity, economic burden, and even mortality. A…”
    Get full text
    Journal Article
  5. 5

    Microbiome-Based Biomarkers for IBD by Ananthakrishnan, Ashwin N

    Published in Inflammatory bowel diseases (01-10-2020)
    “…Abstract Crohn disease and ulcerative colitis are complex immune-mediated diseases that are characterized by a heterogeneity in presentation and clinical…”
    Get full text
    Journal Article
  6. 6

    Treat to Target: The Role of Histologic Healing in Inflammatory Bowel Diseases: A Systematic Review and Meta-analysis by Gupta, Akshita, Yu, Amy, Peyrin-Biroulet, Laurent, Ananthakrishnan, Ashwin N.

    Published in Clinical gastroenterology and hepatology (01-09-2021)
    “…Endoscopic remission is a recognized therapeutic endpoint in inflammatory bowel disease (IBD; Crohn’s disease (CD), ulcerative colitis (UC)). The impact of…”
    Get full text
    Journal Article
  7. 7

    The emergence of Clostridium difficile infection in Asia: A systematic review and meta-analysis of incidence and impact by Borren, Nienke Z, Ghadermarzi, Shadi, Hutfless, Susan, Ananthakrishnan, Ashwin N

    Published in PloS one (02-05-2017)
    “…Clostridium difficile infection (CDI) is the most common healthcare associated infection and is highly prevalent in Europe and North America. Limited data is…”
    Get full text
    Journal Article
  8. 8

    Ulcerative Colitis and Crohn’s Disease Have Similar Burden and Goals for Treatment by Le Berre, Catherine, Ananthakrishnan, Ashwin N., Danese, Silvio, Singh, Siddharth, Peyrin-Biroulet, Laurent

    Published in Clinical gastroenterology and hepatology (01-01-2020)
    “…It is unclear whether ulcerative colitis (UC) is a progressive disease similar to Crohn’s disease (CD). Patients with UC often are undertreated because of the…”
    Get full text
    Journal Article
  9. 9

    Review article: vitamin D and inflammatory bowel diseases by Mouli, V. P., Ananthakrishnan, A. N.

    Published in Alimentary pharmacology & therapeutics (01-01-2014)
    “…Summary Background Vitamin D is traditionally associated with bone metabolism. The immunological effects of vitamin D have increasingly come into focus. Aim To…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Gut Microbiome Function Predicts Response to Anti-integrin Biologic Therapy in Inflammatory Bowel Diseases by Ananthakrishnan, Ashwin N., Luo, Chengwei, Yajnik, Vijay, Khalili, Hamed, Garber, John J., Stevens, Betsy W., Cleland, Thomas, Xavier, Ramnik J.

    Published in Cell host & microbe (10-05-2017)
    “…The gut microbiome plays a central role in inflammatory bowel diseases (IBDs) pathogenesis and propagation. To determine whether the gut microbiome may predict…”
    Get full text
    Journal Article
  12. 12

    The role of diet in the aetiopathogenesis of inflammatory bowel disease by Khalili, Hamed, Chan, Simon S. M., Lochhead, Paul, Ananthakrishnan, Ashwin N., Hart, Andrew R., Chan, Andrew T.

    “…Crohn’s disease and ulcerative colitis, collectively known as IBD, are chronic inflammatory disorders of the gastrointestinal tract. Although the…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Multi-omics reveal microbial determinants impacting responses to biologic therapies in inflammatory bowel disease by Lee, Jonathan Wei Jie, Plichta, Damian, Hogstrom, Larson, Borren, Nynke Z., Lau, Helena, Gregory, Sara M., Tan, William, Khalili, Hamed, Clish, Clary, Vlamakis, Hera, Xavier, Ramnik J., Ananthakrishnan, Ashwin N.

    Published in Cell host & microbe (11-08-2021)
    “…The intestinal microbiome is a key determinant of responses to biologic therapy in inflammatory bowel disease (IBD). However, diverse therapeutics and variable…”
    Get full text
    Journal Article
  15. 15

    Development of phenotype algorithms using electronic medical records and incorporating natural language processing by Liao, Katherine P, Cai, Tianxi, Savova, Guergana K, Murphy, Shawn N, Karlson, Elizabeth W, Ananthakrishnan, Ashwin N, Gainer, Vivian S, Shaw, Stanley Y, Xia, Zongqi, Szolovits, Peter, Churchill, Susanne, Kohane, Isaac

    Published in BMJ (Online) (24-04-2015)
    “…Electronic medical records are emerging as a major source of data for clinical and translational research studies, although phenotypes of interest need to be…”
    Get full text
    Journal Article
  16. 16

    A Prospective Study of Long-term Intake of Dietary Fiber and Risk of Crohn's Disease and Ulcerative Colitis by Ananthakrishnan, Ashwin N, Khalili, Hamed, Konijeti, Gauree G, Higuchi, Leslie M, de Silva, Punyanganie, Korzenik, Joshua R, Fuchs, Charles S, Willett, Walter C, Richter, James M, Chan, Andrew T

    Published in Gastroenterology (New York, N.Y. 1943) (01-11-2013)
    “…Background & Aims Increased intake of dietary fiber has been proposed to reduce the risk of inflammatory bowel disease (Crohn's disease [CD] and ulcerative…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Long-term intake of dietary fat and risk of ulcerative colitis and Crohn's disease by Ananthakrishnan, Ashwin N, Khalili, Hamed, Konijeti, Gauree G, Higuchi, Leslie M, de Silva, Punyanganie, Fuchs, Charles S, Willett, Walter C, Richter, James M, Chan, Andrew T

    Published in Gut (01-05-2014)
    “…Dietary fats influence intestinal inflammation and regulate mucosal immunity. Data on the association between dietary fat and risk of Crohn's disease (CD) and…”
    Get more information
    Journal Article
  19. 19

    Systematic review with meta‐analysis: comparative efficacy of biologics for induction and maintenance of mucosal healing in Crohn's disease and ulcerative colitis controlled trials by Cholapranee, A., Hazlewood, G. S, Kaplan, G. G., Peyrin‐Biroulet, L., Ananthakrishnan, A. N.

    Published in Alimentary pharmacology & therapeutics (01-05-2017)
    “…Summary Background Mucosal healing is an important therapeutic endpoint in the management of Crohn's disease (CD) and ulcerative colitis (UC). Limited data…”
    Get full text
    Journal Article
  20. 20